4//SEC Filing
CYTOKINETICS INC 4
Accession 0001061983-17-000020
$CYTKCIK 0001061983operating
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 7:07 PM ET
Size
11.6 KB
Accession
0001061983-17-000020
Insider Transaction Report
Form 4
CYTOKINETICS INCCYTK
WOLFF ANDREW A
SVP Clinical R&D, CMO
Transactions
- Award
Common Stock
2017-02-28$0.00/sh+12,500$13→ 37,239 total - Award
Common Stock
2017-02-28$0.00/sh+15,000$15→ 47,255 total - Award
Non-Qualified Stock Option (right to buy)
2017-02-28+8,580→ 8,580 totalExercise: $10.60Exp: 2027-02-28→ Common Stock (8,580 underlying) - Award
Incentive Stock Option (right to buy)
2017-02-28+6,420→ 6,420 totalExercise: $10.60Exp: 2027-02-28→ Common Stock (6,420 underlying) - Tax Payment
Common Stock
2017-02-28$10.60/sh−4,984$52,830→ 32,255 total
Footnotes (2)
- [F1]The restricted stock units vest in three annual installments. Vested shares will be delivered to the reporting person as follows: 40% on 02/28/2018, 40% on 02/28/2019 and 20% on 02/28/2020.
- [F2]When the ISO and NQ dated 02/28/2017 are combined, the total grant shall vest and become exercisable in equal monthly installments such that the option shall be 100% vested on 02/28/2021.
Documents
Issuer
CYTOKINETICS INC
CIK 0001061983
Entity typeoperating
Related Parties
1- filerCIK 0001061983
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 7:07 PM ET
- Size
- 11.6 KB